Literature DB >> 23817928

Helicobacter pylori and gastritis: the role of extracellular matrix metalloproteases, their inhibitors, and the disintegrins and metalloproteases--a systematic literature review.

Clara L Sampieri1.   

Abstract

Helicobacter pylori (H. pylori) is the etiologic agent of gastritis; it has been estimated that 50 % of the world's population could be infected by this bacteria. Gastritis may progress to chronic atrophic gastritis, a condition associated with the development of gastric cancer (GC). Several matrix metalloproteases (MMP) and tissue inhibitors of MMPs (TIMP) as well as disintegrins and metalloproteases (ADAM) have been reported as being involved in gastritis. Among other processes, these protein families participate in remodeling the extracellular matrix, cell signaling, immune response, angiogenesis, inflammation and epithelial mesenchymal transition. This systematic review analyzes the scientific evidence surrounding the relationship between members of the MMP, TIMP and ADAM families and infection by H. pylori in gastritis, considering both in vitro and in vivo studies. Given the potential clinical value of certain members of the MMP, TIMP and ADAM families as molecular markers in gastritis and the association of gastritis with GC, the need for further study is highlighted.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23817928     DOI: 10.1007/s10620-013-2767-x

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  53 in total

1.  ADAMs (a disintegrin and metalloproteinase) messenger RNA expression in Helicobacter pylori-infected, normal, and neoplastic gastric mucosa.

Authors:  Tetsuro Yoshimura; Toshihiko Tomita; Michael F Dixon; Anthony T R Axon; Philip A Robinson; Jean E Crabtree
Journal:  J Infect Dis       Date:  2002-01-17       Impact factor: 5.226

2.  Mucosal IgA recognition of Helicobacter pylori 120 kDa protein, peptic ulceration, and gastric pathology.

Authors:  J E Crabtree; J D Taylor; J I Wyatt; R V Heatley; T M Shallcross; D S Tompkins; B J Rathbone
Journal:  Lancet       Date:  1991-08-10       Impact factor: 79.321

3.  Role of MMP-7 in the formation of peritoneal dissemination in gastric cancer.

Authors:  Yutaka Yonemura; Yoshio Endou; Hideto Fujita; Sachio Fushida; Etsurou Bandou; Keizou Taniguchi; Kouichi Miwa; Kazuo Sugiyama; Takuma Sasaki
Journal:  Gastric Cancer       Date:  2000-09-29       Impact factor: 7.370

4.  Epithelial and bacterial metalloproteinases and their inhibitors in H. pylori infection of human gastric cells.

Authors:  M Göõz; P Göõz; A J Smolka
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

5.  Assessment of systemic matrix metalloproteinase and their regulator response in children with Helicobacter pylori gastritis.

Authors:  Hilpi Rautelin; Taina Tervahartiala; Anneli Lauhio; Timo Sorsa; Kaija-Leena Kolho
Journal:  Scand J Clin Lab Invest       Date:  2010-09-21       Impact factor: 1.713

6.  Helicobacter pylori potentiates epithelial:mesenchymal transition in gastric cancer: links to soluble HB-EGF, gastrin and matrix metalloproteinase-7.

Authors:  Yinfei Yin; Anna M Grabowska; Philip A Clarke; Elisabeth Whelband; Karen Robinson; Richard H Argent; Amanda Tobias; Rajendra Kumari; John C Atherton; Susan A Watson
Journal:  Gut       Date:  2010-06-28       Impact factor: 23.059

Review 7.  Helicobacter pylori as a class I carcinogen: physiopathology and management strategies.

Authors:  Paraskevi Vogiatzi; Marco Cassone; Ida Luzzi; Chiara Lucchetti; Laszlo Otvos; Antonio Giordano
Journal:  J Cell Biochem       Date:  2007-10-01       Impact factor: 4.429

8.  Enhanced systemic matrix metalloproteinase response in Helicobacter pylori gastritis.

Authors:  Hilpi I Rautelin; Aino M Oksanen; Lea I Veijola; Pentti I Sipponen; Taina I Tervahartiala; Timo A Sorsa; Anneli Lauhio
Journal:  Ann Med       Date:  2009       Impact factor: 4.709

Review 9.  Clinical aspects of Helicobacter pylori infection.

Authors:  Witold Bartnik
Journal:  Pol Arch Med Wewn       Date:  2008 Jul-Aug

10.  Significance of cell-surface expression of matrix metalloproteinases and their inhibitors on gastric epithelium and infiltrating mucosal lymphocytes in progression of Helicobacter pylori-associated gastritis.

Authors:  S Koyama
Journal:  Scand J Gastroenterol       Date:  2004-11       Impact factor: 2.423

View more
  6 in total

1.  Prevalence of Gastric Preneoplastic Lesions in First-Degree Relatives of Patients with Gastric Cancer: a Cross-Sectional Study.

Authors:  Sergio Sotelo; Carlos Manterola; Tamara Otzen; Erik Morales; Iván Castillo
Journal:  J Gastrointest Cancer       Date:  2022-04-30

Review 2.  Role of LPS-elicited signaling in triggering gastric mucosal inflammatory responses to H. pylori: modulatory effect of ghrelin.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2017-05-17       Impact factor: 4.473

3.  Role of protein kinase D2 phosphorylation on Tyr in modulation by ghrelin of Helicobacter pylori-induced up-regulation in gastric mucosal matrix metalloproteinase-9 (MMP-9) secretion.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2016-05-21       Impact factor: 4.473

4.  Helicobacter pylori-induced changes in microtubule dynamics conferred by α-tubulin phosphorylation on Ser/Tyr mediate gastric mucosal secretion of matrix metalloproteinase-9 (MMP-9) and its modulation by ghrelin.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2016-09-09       Impact factor: 4.473

5.  Helicobacter pylori-elicited induction in gastric mucosal matrix metalloproteinase-9 (MMP-9) release involves ERK-dependent cPLA2 activation and its recruitment to the membrane-localized Rac1/p38 complex.

Authors:  B L Slomiany; A Slomiany
Journal:  Inflammopharmacology       Date:  2016-02-17       Impact factor: 4.473

Review 6.  Proteolytic Landscapes in Gastric Pathology and Cancerogenesis.

Authors:  Sabine Bernegger; Miroslaw Jarzab; Silja Wessler; Gernot Posselt
Journal:  Int J Mol Sci       Date:  2022-02-22       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.